Health Care Equipment

ACCELERATE DIAGNOSTICS INC

Accelerate Diagnostics Inc. released FY2023 Q4 earnings on March 21 (EST), actual revenue USD 3.027 M (forecast USD 3.45 M), actual EPS USD -0.8916

Accelerate Diagnostics Inc. released FY2024 Q4 earnings on March 21 (EST), actual revenue USD 2.816 M (forecast USD 3 M), actual EPS USD -0.3804

Accelerate Diagnostics Inc. released FY2023 earnings on March 21 (EST), actual revenue USD 12.06 M (forecast USD 12.45 M), actual EPS USD -4.9385

Accelerate Diagnostics Inc. released FY2024 earnings on March 21 (EST), actual revenue USD 11.7 M (forecast USD 11.9 M), actual EPS USD -2.1476

Accelerate Diagnostics Inc. released FY2023 Q3 earnings on November 7 (EST), actual revenue USD 3.299 M (forecast USD 3.55 M), actual EPS USD 0.063

Accelerate Diagnostics Inc. released FY2024 9 Months Earnings on November 7, 2024 (EST) with actual revenue of USD 8.882 M and EPS of USD -1.8306

Accelerate Diagnostics Inc. released FY2024 Q3 earnings on November 7, 2024 (EST), actual revenue USD 2.975 M (forecast USD 3 M), actual EPS USD -0.5875

Accelerate Diagnostics Inc. released FY2023 9 Months Earnings on November 7, 2024 (EST), with actual revenue of USD 9.032 M and EPS of USD -4.6204

Accelerate Diagnostics Inc. released FY2023 Q2 earnings on August 8, 2024 (EST), with actual revenue of USD 2.921 M (forecast USD 3.6 M) and actual EPS of USD -2.9734

Accelerate Diagnostics Inc. released FY2024 Semi-Annual Earnings on August 8, 2024 (EST), with actual revenue of USD 5.907 M and EPS of USD -1.1603

Accelerate Diagnostics Inc. released FY2023 Semi-Annual Earnings on August 8, 2024 (EST), with actual revenue of USD 5.733 M and EPS of USD -4.7533

Accelerate Diagnostics Inc. released FY2024 Q2 earnings on August 8, 2024 (EST), actual revenue USD 2.986 M (forecast USD 3 M), actual EPS USD -0.5025

Accelerate Diagnostics Inc. released FY2023 Q1 earnings on May 13 (EST), actual revenue USD 2.812 M (forecast USD 3.35 M), actual EPS USD -1.71

Accelerate Diagnostics Inc. released FY2024 Q1 earnings on May 13 (EST), actual revenue USD 2.921 M (forecast USD 3 M), actual EPS USD -0.7405

Xiao I

Huachen AI Parking Management Tech

Quince Therapeutics

Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc.

IP Strategy

Cemtrex

Corvex

Hub Cyber Security

LanzaTech Global

Cuprina

Delcath

雅培

直觉外科

史赛克

波士顿科学

爱德华生命科学

IDEXX实验室

瑞思迈

德康医疗

STERIS

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

ACCELERATE DIAGNOSTICS INC(AXDXQ.US)

ACCELERATE DIAGNOSTICS INC Stock Performance Chart